留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

术前门静脉血栓对终末期肝硬化患者行肝移植手术的影响

孟炜,  赵辉,  易述红,  张彤,  傅斌生,  汪国营,  许赤,  李华,  杨扬,  陈规划

downloadPDF
文章导航 > 器官移植  > 2015 >  6(5): 322-325
孟炜, 赵辉, 易述红, 等. 术前门静脉血栓对终末期肝硬化患者行肝移植手术的影响[J]. 器官移植, 2015, 6(5): 322-325. doi: 10.3969/j.issn.1674-7445.2015.05.009
引用本文: 孟炜, 赵辉, 易述红, 等. 术前门静脉血栓对终末期肝硬化患者行肝移植手术的影响[J]. 器官移植, 2015, 6(5): 322-325. doi: 10.3969/j.issn.1674-7445.2015.05.009
shu
Meng Wei, Zhao Hui, Yi Shuhong, et al. Effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis[J]. ORGAN TRANSPLANTATION, 2015, 6(5): 322-325. doi: 10.3969/j.issn.1674-7445.2015.05.009
Citation: Meng Wei, Zhao Hui, Yi Shuhong, et al. Effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis[J]. ORGAN TRANSPLANTATION, 2015, 6(5): 322-325. doi: 10.3969/j.issn.1674-7445.2015.05.009
shu

术前门静脉血栓对终末期肝硬化患者行肝移植手术的影响

doi: 10.3969/j.issn.1674-7445.2015.05.009

  • 510630 广州, 中山大学附属第三医院肝脏外科

基金项目: 

国家十二五重大科技专项 2012ZX10002017-005

国家十二五重大科技专项 2012ZX10002016-011

国家十二五重大科技专项 2012ZX10002010-001-007

国家自然科学基金 81170451

国家自然科学基金 81172038

国家自然科学基金 81372243

国家自然科学基金 81370575

国家自然科学基金 81370555

教育部博士点基金 20120171110082

广东省自然科学基金 S20120011190

广州市科技重大专项 201400000001-3

详细信息

  • 中图分类号: R617

Effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis

  • Department of Hepatic Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

More Information
    Corresponding author: 陈规划, Email:chgh1955@263.net Chen Guihua,Email:chgh1955@263.net

    摘要
  • 摘要:   目的  探讨术前门静脉血栓对终末期肝硬化患者行肝移植的影响。  方法  回顾性分析2007年1月至2011年12月在中山大学附属第三医院器官移植中心接受肝移植手术的182例终末期肝硬化患者的临床资料。将合并门静脉血栓的13例(Yerdel分级Ⅰ级3例, Ⅱ级6例, Ⅲ级2例, Ⅳ级2例)患者作为门静脉血栓组, 其余169例无门静脉血栓的患者作为对照组。比较两组患者肝移植术中和术后情况。  结果  与对照组比较, 门静脉血栓组的手术时间和术中出血量较多(均为P < 0.05), Ⅲ~Ⅳ级血栓者的手术时间和术中出血量亦较多(均为P < 0.05)。术后1个月, 门静脉血栓组发生门静脉血栓1例(8%), 对照组发生3例(2%), 两组比较差异有统计学意义(P < 0.05)。门静脉血栓组术后3年存活率为46%(6/13), 对照组相应为84%(142/169), 两组比较差异有统计学意义(P < 0.05)。  结论  Ⅲ~Ⅳ级门静脉血栓会明显增加肝移植手术难度和风险, 但只要术前严格评估门静脉血栓情况, 术中采用合理的门静脉重建方式, 依然可以取得良好的疗效。

     

    Abstract:   Objective  To investigate the effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis.  Methods  Clinical data of 182 patients with end-stage liver cirrhosis undergoing liver transplantation at the Organ Transplantation Center of the Third Affiliated Hospital, Sun Yat-sen University from January 2007 to December 2011 were retrospectively studied. Thirteen patients complicated with portal venous thrombosis (3 patients were in Yerdel gradeⅠ, 6 were in grade Ⅱ, 2 were in grade Ⅲ and 2 were in grade Ⅳ) were divided into the portal venous thrombosis group. Other 169 patients without portal venous thrombosis were divided into the control group. The intra-operative and postoperative conditions of patients were compared between two groups.  Results  Compared with the control group, there were longer operation time, more intra-operative blood loss in the portal venous thrombosis group and the patient with Yerdel grade Ⅲ-Ⅳ. There was significant difference (both in P < 0.05). At one month after transplantation, one patient (8%) in the portal venous thrombosis group and three patients (2%) in the control group developed portal venous thrombosis, and there was significant difference (P < 0.05). Three-year survival rate of the portal venous thrombosis group was 46% (6/13) and that of the control group was 84% (142/169), and there was significant difference (P < 0.05).  Conclusions  Portal venous thrombosis of grade Ⅲ and Ⅳ may significantly increase the difficulty and risks of liver transplantation. However, the good curative effect may also be obtained only when the portal venous thrombosis is strictly assessed, and the rational portal venous reconstruction method is used during the operation.

     

    • HTML全文
    • 参考文献(19)
  • [1] Zhou GW. Treatment for portal venous complications after orthotopic liver transplantation and evaluation of long-term curative effect[J]. Organ Transplant, 2013, 4(6):335-338. https://www.ncbi.nlm.nih.gov/pubmed/16549187
    [2] 周光文.原位肝移植术后门静脉并发症处理及远期疗效评估[J].器官移植, 2013, 4(6):335-338. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201306006.htm

    Otto G. Liver transplantation:an appraisal of the present situation[J]. Dig Dis, 2013, 31(1):164-169. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201306006.htm
    [3] Schuppan D, Afdhal NH. Liver cirrhosis[J]. Lancet, 2008, 371(9615):838-851. doi: 10.1016/S0140-6736(08)60383-9
    [4] Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation:usefulness of screening and anticoagulation[J]. Gut, 2005, 54(5):691-697. doi: 10.1136/gut.2004.042796
    [5] Garcia-Pagan JC, Valla DC. Portal vein thrombosis:a predictable milestone in cirrhosis?[J]. J Hepatol, 2009, 51(4):632-634. doi: 10.1016/j.jhep.2009.06.009
    [6] 李洋.门静脉血栓与肝移植[J].器官移植, 2013, 4(3):165-168. http://www.cnki.com.cn/Article/CJFDTotal-QGYZ201303011.htm

    Li Y. Portal vein thrombosis and liver transplantation[J]. Organ Transplant, 2013, 4(3):165-168. http://www.cnki.com.cn/Article/CJFDTotal-QGYZ201303011.htm
    [7] Rodríguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation:a systematic review[J]. Transplantation, 2012, 94(11):1145-1153. doi: 10.1097/TP.0b013e31826e8e53
    [8] Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(7):435-446. doi: 10.1038/nrgastro.2014.36
    [9] Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51(4):682-689. doi: 10.1016/j.jhep.2009.03.013
    [10] Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis:predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4):568-574. doi: 10.1038/ajg.2012.452
    [11] Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation:evolution during 10 years of experience at the University of Bologna[J]. Ann Surg, 2011, 253(2):378-384. doi: 10.1097/SLA.0b013e318206818b
    [12] Suarez Artacho G, Barrera Pulido L, Alamo Martinez JM, et al. Outcomes of liver transplantation in candidates with portal vein thrombosis[J]. Transplant Proc, 2010, 42(8):3156-3158. doi: 10.1016/j.transproceed.2010.05.057
    [13] 陈国富, 范国华.脾切除术后门静脉系统血栓形成的临床分析[J].中国普外基础与临床杂志, 2012, 19(6):649-652. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm

    Chen GF, Fan GH. Clinical analysis of portal vein thrombosis after splenectomy[J]. Chin J Bases Clin Gen Surg, 2012, 19(6):649-652. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm
    [14] 卢焕元, 黄飞舟, 聂晚频, 等.肝硬化门静脉高压症患者食管静脉曲张套扎术后复发再出血治疗方法的选择[J/CD].中华肝脏外科手术学电子杂志, 2012, 1(2):79-84. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm

    Lu HY, Huang FZ, Nie WP, et al. Treatment selection for hepatocirrhosis portal hypertension patients with recurrent hemorrhage after endoscopic variceal ligation[J/CD]. Chin J Hepat Surg: Electr Edit,2012,1(2):79-84. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm
    [15] 邹俊, 李学明, 陈海鸣, 等.门静脉高压症脾切除贲门周围血管离断术后门静脉血栓形成的相关因素分析[J].实用医学杂志, 2013, 29(4):581-583. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201304032.htm

    Zou J, Li XM, Chen HM, et al. The related factors analysis on portal vein thrombosis after portal hypertension of splenectomy cardiac peripheral vascular[J]. J Pract Med, 2013, 29(4):581-583. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201304032.htm
    [16] Lai Q, Spoletini G, Pinheiro RS, et al. From portal to splanchnic venous thrombosis:what surgeons should bear in mind[J]. World J Hepatol, 2014, 6(8):549-558. https://www.ncbi.nlm.nih.gov/pubmed/25232448
    [17] Paskonis M, Jurgaitis J, Mehrabi A, et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis:current role of cavoportal hemitransposition and renoportal anastomosis[J]. Clin Transplant, 2006, 20(5):551-562. doi: 10.1111/ctr.2006.20.issue-5
    [18] Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis[J]. Am J Transplant, 2007, 7(2):454-460. doi: 10.1111/ajt.2007.7.issue-2
    [19] Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation:a critical audit of 174 cases[J]. Ann Surg, 2014, 259(4):760-766. doi: 10.1097/SLA.0000000000000252
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  122
  • HTML全文浏览量:  38
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-07-31
  • 网络出版日期:  2021-04-29
  • 刊出日期:  2015-09-01

目录

    /

    返回文章
    返回

    《器官移植》微信订阅号

    《器官移植》微信服务号

    联系我们
    • 电话: 020-38736410
    • Email: organtranspl@163.com
    • 地址: 广州市天河区天河路600号中山大学附属第三医院（广州）期刊有限责任公司
    • 《器官移植》编辑部  粤ICP备2021030844号
    友情链接

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计